Status:

COMPLETED

A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa

Lead Sponsor:

University of Colorado, Denver

Collaborating Sponsors:

Janssen Pharmaceuticals

National Center for Research Resources (NCRR)

Conditions:

Anorexia Nervosa

Eligibility:

FEMALE

12-21 years

Phase:

PHASE4

Brief Summary

The aim of this pilot study is to determine the safety and efficacy of risperidone for the treatment of anorexia nervosa. Hypothesis 1: Subjects on risperidone will show a more significant decrease i...

Detailed Description

The lack of effective medications for the symptoms of anorexia nervosa (AN), combined with early promising findings in case reports (Risperidone and Olanzapine) and one open study of olanzapine have l...

Eligibility Criteria

Inclusion

  • Primary Diagnosis of Anorexia Nervosa
  • Female, age 12-21
  • Active in a level of care for AN at The Children's Hospital, Denver
  • As long as there is a primary dx of AN, co-morbid diagnoses may be included.
  • If taking an antidepressant, must be on a stable dose for 3 weeks prior to entering the study, and dose of antidepressant may not be changed during Phase 1 of the study.
  • If choosing to discontinue antidepressant medication, must be off the medication for 3 weeks prior to beginning the study.
  • If sexually active, must use birth control during the study and have a monthly pregnancy test.

Exclusion

  • Previous enrollment in this study on a prior admission
  • Previous allergic reaction to risperidone or other atypical neuroleptic
  • Positive pregnancy test
  • Neurologic disorder other than benign essential tremor
  • Taking a psychotropic medication other than antidepressant and discontinuing the medication is not recommended.
  • Active hepatic or renal disease
  • Wards of the state
  • Males

Key Trial Info

Start Date :

August 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2009

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT00140426

Start Date

August 1 2004

End Date

December 1 2009

Last Update

February 2 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Children's Hospital

Denver, Colorado, United States, 80218